Buffett's confidence in troubled decade-old acquisition finally pays off

GE Aerospace's $11.75 billion acquisition of Precision Castparts competitor Consolidated Precision Products at roughly 26x projected 2027 EBITDA implies Berkshire Hathaway's Precision Castparts unit could be worth about $100 billion, according to Barron's. That is nearly triple Berkshire's 2016 $37.2 billion purchase price and far above the $11 billion writedown recorded in 2020, as shortages of turbine components support aerospace and AI data-center power demand. Berkshire Class A and B shares rose about 0.9% this week while the S&P 500 declined 0.8%, though BRK.B still trails the index by more than 10 percentage points year-to-date.

Analysis

The relevant signal for BRK.A is not a mark-to-market appraisal of Precision Castparts, but a shift in the earnings-quality debate: constrained, qualification-intensive castings can convert aerospace and power-generation backlog into multi-year pricing power. If PCP is operating near capacity, incremental revenue should carry high contribution margins because certification, tooling, and customer switching costs limit rapid competitive response. This creates a plausible path for Berkshire's industrial earnings to surprise upward over the next 4-8 quarters, while the market continues to value the conglomerate primarily on insurance investment income and its equity portfolio.

GE's purchase raises both strategic and valuation questions. Owning scarce component capacity can protect GE Aerospace's engine delivery schedule and aftermarket installed-base economics, but paying a premium multiple only creates value if avoided production bottlenecks and internal transfer pricing outweigh the foregone returns on capital. Near-term, the transaction is supportive of GE's delivery-risk narrative; over 12-24 months, it is a negative read-through for standalone aerospace suppliers lacking scale, as OEMs may seek to internalize other constrained nodes in the supply chain.

Consensus may be too focused on a headline private-market multiple as direct evidence of BRK.A upside. PCP's value is economically real but not readily monetizable, and a higher internal estimate does not automatically narrow Berkshire's conglomerate discount absent clearer segment disclosure, sustained margin evidence, or materially larger repurchases. The more actionable second-order beneficiary is the gas-turbine supply chain: data-center power demand extends the scarcity cycle beyond civil aerospace, favoring GE and potentially Siemens Energy (ENR.DE) over equipment customers exposed to delayed grid and turbine availability.

Key Decisions for Investors

• Accumulate BRK.B (or BRK.A for size) on broad-market weakness over a 6-18 month horizon; thesis is industrial earnings optionality plus capital deployment, not a near-term sum-of-the-parts rerating. Reassess if PCP-related industrial margins fail to improve through the next two reporting cycles or if buybacks slow materially despite a wider discount to intrinsic value.
• Maintain a tactical long GE position for 1-3 months into transaction-close and production-update catalysts, but size modestly: supply assurance can support delivery guidance, while the acquisition multiple leaves limited room for execution misses. Exit on a cut to engine-delivery or free-cash-flow guidance; pair against XLI if seeking to isolate company-specific execution.
• Watch-list long ENR.DE versus a short basket of power-intensive data-center beneficiaries if turbine lead times continue extending. The trade requires confirmation from order backlog, pricing, and capacity commentary; without those data, do not initiate solely on the AI-power narrative.
• Avoid treating the private transaction multiple as a standalone BRK rerating catalyst. Add only if Berkshire provides segment-level evidence of PCP revenue, margin, or backlog acceleration, or if the market price implies a materially more attractive discount than current conglomerate valuation.